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How Ras works: structure of a Rap-Raf complex
The three-dimensional structure of the complex between Rap and the 'Ras-binding
domain' of Raf could be the prototype for a G protein-effector interaction.
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Last month in Nature, Wittinghofer and colleagues [1]
revealed the first three-dimensional structure of a com-
plex between a member of the G-protein superfamily and
its effector, that is the downstream molecule through
which the G protein acts in signal transduction. This new
structure determination brings us closer to an under-
standing of Ras-mediated signal transduction. The story,
strictly speaking, is not about Ras, but many of the essen-
tial players are the same. It begins with the activation of a
cytosolic serine/threonine-specific protein kinase called
c-Raf-1 [2] - originally identified as an oncogenic com-
ponent of the murine sarcoma virus - by a receptor-
linked tyrosine kinase, through a mechanism that is not
fully understood. To be activated, Raf must first be lured
to the plasma membrane [3]. This is the task of Ras, a
small GTP hydrolase tethered by farnesylation to the inner
leaflet of the plasma membrane. The active, GTP-bound,
form of Ras binds to an 80 residue subdomain within the
N-terminal regulatory region of Raf [4]. Activation by
Ras is inhibited by Rap which is also a small GTP-bind-
ing protein and has an effector-binding region (residues
32-40) that is identical to that in Ras. Rap was identified
as a suppressor of the transformed phenotype induced by
v-Ras K in cultured cells [5], and interacts strongly with
Ras in a two-hybrid system [6]. The mechanism by which
Rap inhibits the activity of Ras is not well understood;
one possibility is that it interferes with the process by
which Raf is localized to the plasma membrane [2].
The structure, at 2.8 A resolution, determined by Nassar
et al. [1] is that of the Rap-Raf complex - or, to be
more precise, that of Rap bound to the non-hydrolyzable
GTP analog, GppNHp, and in a complex with the Ras-
binding domain (RBD) of Raf (residues 51-131) [1]. As
Rap is a potent competitor of Ras (which itself binds Raf
with a 20 nM affinity [2]), it is probable that the Rap-
Raf complex will be found to recapitulate the essential
features of the active Ras-Raf signaling species. This first
glimpse of a G protein, Rap, interacting with its effector,
Raf, therefore particularly provokes our curiosity. Where
is the effector-binding surface of a Ras homolog? How is
it physically linked to the site of GTP hydrolysis, and can
one discern how the hydrolytic event alters the affinity of
Ras for its effector? Finally, can the general features of
the Rap-Raf complex be extrapolated to other members
of the Ras superfamily - particularly to the subunits
of the heterotrimeric G protein?
Consistent with an earlier NMR determination [7], the
RBD of Raf is a ubiquitin ot/3-roll [8] remarkably similar
to that found in ubiquitin itself, even though the primary
sequence similarity of the two proteins is insignificant.
Rap is virtually identical to Ras, with the exception of
small insertions in two helical regions. Indeed, the crystal-
lographic structure of the complex [1] was bootstrapped
by molecular replacement using .the coordinates of
Ras.GppNHp [9] as the sole source of phasing informa-
tion (as was the case with Ras, crystals of Rap were pre-
pared using a truncated protein lacking residues 168-186).
The largest differences between Ras and Rap are found
within those regions of the structure that, in Ras, are the
most conformationally responsive to nucleotide hydrolysis
[9,10]: the effector-binding loop at Tyr32, Thr35 and
Ile36 and residues 65-71 from the (x2 (switch II) helix.
The GTP-binding site is highly conserved between the
two proteins, although it appears that Rap forms closer
contacts with the ribose and y-phosphate moieties. Like
the GTP-analog complexes of Ras [9,10], transducin a
(Gta) [11] and, the inhibitory G protein, Gi.l [12], the
Rap-Raf complex is trapped at the threshold of the tran-
sition state for GTP hydrolysis with a hydrolytic water
poised for nucleophilic attack. In the complex, there is a
channel large enough to admit the water molecule and
expel the phosphate generated by hydrolysis. The RBD is,
in fact, an inhibitor of guanine nucleotide exchange [13].
To form the complex, the 13-sheets of RBD and Rap are
joined edge-to-edge such that the 132 strand of Rap and
the B2 strand of the RBD form an antiparallel 13-ribbon
(Fig. la). In fact, side-chain interactions predominate in
the inter-strand contact. The complex buries a substantial
accessible surface area of 1255 A2, and the interacting sur-
faces are remarkably complementary. Unlike the hydro-
phobic interfaces characteristic of many stable, oligo-
meric proteins [14], the contacts between Rap and the
RBD are largely polar, including three which are ionic.
For proteins diffusing in the two-dimensional plane of
the plasma membrane, contacts may not have to be
highly stable to promote association, but they must be
highly specific, so that the correct partners engage.
There is a satisfying correspondence between the resi-
dues seen to be involved in the Rap-Raf interaction sur-
face [1] and those defined genetically as comprising the
effector-binding region of Ras (residues 32-40) [15].
Some of the more prominent non-transforming muta-
tions in Ras, for example Asp38--Glu, can be explained
as disruptions of the interface. Similarly, mutation of Raf
Arg89, the interaction partner of Ras Asp38, abolishes
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the Rap-Raf complex. The origin of the conformational
switch can clearly be attributed to the rearrangements of
Rap Tyr35 and Tyr32, as depicted in Figure 2 using Ras
as a model. These result in the formation of the binding
subsite near Asp38, which forms the central Rap Asp38
Raf Arg89 contact. However, the ca2 (switch II) helix
does not contribute to the binding surface.
Could the ot subunits of heterotrimeric G proteins and
the Ras family members (i.e. monomeric G proteins)
utilize analogous effector-binding sites? Mutagenic and
peptide-binding studies of the heterotrimeric G-protein
ao subunit, Gsa, suggest that the distal region of the 0a2
(switch II) helix and two polypeptide loops - all located
in the 'Ras-like' domain, are involved in effector binding
by Gsa [16]. These do not correspond to the effector-
binding surface of Rap, however. As the crystal structures
of both Gta and Gial demonstrate, their ao subunits con-
tain a -100-residue or-helical insertion between the ael
helix and 2 strand of the 'Ras-like' domain of Ga. This
insertion packs against the GTP-binding surface of the
Ras domain. If Gial and the Rap-Raf complex are both
viewed from the same perspective (Fig. lb) it is evident
the RBD and the a-helical insertion occupy distinct but
perhaps only partially overlapping positions relative to the
Ras domain. In this context, it is intriguing that, in crys-
tals of the GDP-bound Gial, the locus corresponding to
the Raf-binding site of Rap is occupied by a micro-
domain formed by the N and C termini of an adjacent
Fig. 1. Ribbon representations [171 of (a) the Rap-Raf complex
with Rap in yellow and Ras in red (reproduced from [1], with
permission) and (b) G ,1 112], with the Ras domain in yellow and
the a-helical insert 1 in red. The guanine nucleotide is shown as
a stick model.
signaling. On the other hand, several of the residues (26,
27, 30, 31 and 45) that functionally distinguish Ras from
Rap - that is, if they are transplanted from Ras into
Rap, they confer upon the latter the transforming phe-
notype of Ras [15] - are close to the interface, but do
not make contact with the RBD. Not all of the genetic
data can, therefore, be rationalized from the structure of
the complex and it is possible that other elements of Raf,
some perhaps outside of the RBD, are involved in the
interaction with Ras and Rap.
GTP hydrolysis reduces the affinity between Ras and Raf
by more than 1000-fold [13]. The Rap-Raf binding sur-
face, however, is not in contact with the nucleotide-bind-
ing site. Nevertheless, it is possible to relate, albeit
indirectly, at least a subset of the conformational changes
that accompany GDP/GTP exchange to the structure of
Fig. 2. A cartoon based on the GppNHp- and GDP-bound struc-
tures of Ras, suggesting how nucleotide exchange generates con-
formational changes that result in the creation of a Raf-binding
site. Side chains, from top to bottom are Tyr32, Asp33, Pro34,
Thr35 and Asp38. Note that the conformation of these residues
in Rap-GppNHp are somewhat different. In the Rap-Raf crystal
structure, the a1 helix (represented by the blue helix loop) and
the 13-strand, B2, (not shown) of Raf form contacts with Glu37
and downstream residues within Rap 2 (see Fig. 1), but not with
Tyr32-Thr35.
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ox subunit (M Mixon et al., unpublished data). The
nature of that interaction is entirely different from the
Rap-Raf contact, and its functional significance is
unknown. However, the structures of Rap-Raf and Gial
suggest that the region near the 'Ras effector' binding
site may form part of a generalized interaction surface
that is sensitive to guanine-nucleotide-dependent confor-
mational changes.
The structure of the Rap-Raf complex has taught us that
subtle rearrangements can create substantial effects - in
this case the possibility of forming an effector-binding
site. Why Rap is inhibitory whereas Ras is not remains a
mystery, but structural studies now in progress may soon
provide the answer.
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